Literature DB >> 10547460

Development of a lyophilized kit formulation for labeling of DNA probes with 99mTc.

O K Hjelstuen1, A M Saetern, H H Tonnesen, P O Bremer, A M Verbruggen.   

Abstract

DNA fragments such as oligodeoxynucleotides (ODNs) are under investigation for a possible utilization in nuclear medicine. Until now, experiments on 99mTc-labeled ODNs in vitro or in vivo have required the application of time-consuming procedures to obtain and control the purity of the radiolabeled compound. A lyophilized labeling kit would ease and improve the reproducibility in further investigations with this class of promising biomolecules; therefore a study was initiated to evaluate the suitability of conjugates of ODNs and a bifunctional chelating agent to be part of lyophilized kit formulations. We report here the development of the first kit for one-step labeling of oligonucleotides with 99mTc. The formulation comprises 250-500 pmol S-benzoyl-mercaptoacetyldiglycine (MAG2)-ODN phosphorothioate conjugate, 5 mg potassium sodium tartrate tetrahydrate and 100 microg stannous chloride dihydrate in a lyophilized kit. Labeling yields above 90% were reproducibly achieved after addition of 0.1-1 GBq pertechnetate and subsequent heating in a boiling water bath. Once formed, the 99mTc-MAG2-ODN complexes were stable for at least 24 h. The shelf life of the kits is at least 10 weeks when stored protected from light at room temperature, but even kits stored at 40 degrees C gave labeling yields above 90% after 10 weeks.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10547460     DOI: 10.1016/s0378-5173(99)00293-8

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  2 in total

1.  Aptamares: a novel class of radiopharmaceutical with diagnostic and therapeutic potential.

Authors:  S Guhlke; M Famulok; H J Biersack
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-11       Impact factor: 9.236

2.  Radiolabeled oligonucleotides for antisense imaging.

Authors:  Arun K Iyer; Jiang He
Journal:  Curr Org Synth       Date:  2011-08-01       Impact factor: 1.975

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.